Covered Stocks

Andrew Tsai

Work

Analyst Andrew Tsai works at JEFFERIES and is focused on the Healthcare sector with 45 price targets and ratings documented since 2019 spanning on 6 stocks. Analyst's average stock valuation to be materialised ratio is 27.33% with an average time for price targets to be met of 119.4 days.

Most recent stock forecast was given on ATHA, Athira Pharma Inc. at 23-Jun-2022.

Andrew Tsai best performing recommendations are on XENE (XENON PHARMACEUTICALS INC).
The best stock recommendation documented was for XENE (XENON PHARMACEUTICALS INC) at 8/30/2021. The price target of $28 was fulfilled within 35 days with a profit of $11.09 (65.58%) receiving and performance score of 18.74.

Average potential price target upside

ATHA ITCI XENE ATAI SAGE VTGN

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

6

$2.2 (57.89%)

16

6 months 30 days ago

0/2 (0%)

$3.18 (47.87%)

Buy

3

$-0.8 (-21.05%)

40

7 months 14 days ago

2/6 (33.33%)

$15.33 (98.58%)

35

Buy

5

$1.2 (31.58%)

36

7 months 14 days ago

0/3 (0%)

$14.74 (129.13%)

16

$12.2 (321.05%)

1 years 1 months 21 days ago

0/1 (0%)

$4.06 (34.00%)

Show more analysts
ATHA ITCI XENE ATAI SAGE VTGN